Status:
ACTIVE_NOT_RECRUITING
Double-task Exercise in Older Adults at Risk of Cognitive Decline (MeMo-Health-Cog-3 Program)
Lead Sponsor:
Instituto Mexicano del Seguro Social
Collaborating Sponsors:
School of Health and Sport Sciences, Chukyo University, Japan.
Facultad de Estudios Superiores Aragón UNAM
Conditions:
Cognitive Decline
Vascular Health
Eligibility:
All Genders
60-65 years
Phase:
NA
Brief Summary
Cerebral small vessel disease is a frequent cause of cognitive disability among older adults (OAs) in Mexico that imposes a significant burden on the health system and OAs' families. We have called th...
Detailed Description
1. Aim: to evaluate two 24-week double-task (aerobic and cognitive) square-stepping exercise programs for older adults (OAs) at risk of cognitive decline - one program with and another without caregiv...
Eligibility Criteria
Inclusion
- Inclusion criteria.
- With 60-75 years of age.
- They have self-reported cognitive concerns (ie, have answered "yes" to the question: "Do you feel like your memory or thinking skills have gotten worse recently?").
- They demonstrate functional independence in activities of daily living and instrumental activities of daily living.
- They have one or more vascular risk factors (eg, type 2 diabetes or hypertension).
- They have symptoms or signs of underlying cognitive dysfunction without a diagnosis of dementia (ie, confirmed by a review of their health records and a Mini Mental State Exam \[MMSE\] score\> 24).
- They have an informal caregiver who accepts to participate.
- Exclusion criteria.
- With depression (score\> 15 according to the Center for Epidemiological Studies Depression Scale - Revised \[CESD-R\]).
- With clinically significant neurological or psychiatric disorders (eg, Parkinson's, schizophrenia).
- With a recent severe cardiovascular event (eg, myocardial infarction, stroke).
- With a major orthopedic condition (eg, severe osteoarthritis).
- With blood pressure that is unsafe for exercise (ie,\> 180/100 mmHg or \<100/60 mmHg).
- With a severe visual or auditory impairment.
- With an unwillingness to adhere to the intervention schedules.
Exclusion
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04068376
Start Date
May 1 2023
End Date
December 1 2026
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rosalinda Sánchez Arenas
Mexico City, Mexico, 06720